Dermatitis News and Research

Latest Dermatitis News and Research

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Nearly 80 percent of peanut-allergic preschool children successfully incorporated peanut-containing foods into their diets after receiving peanut oral immunotherapy (OIT), a clinical trial has found.

10 Aug 2016

Researchers develop new approach to manufacturing mechanical metamaterials

Ill-fitting joint sockets, contact dermatitis and sebaceous cysts are just a few of the problems plaguing prosthetic patients. They are all a result of the pressure that their prosthetic devices place on the soft tissue of their bodies.

29 Jul 2016

Eczema can increase patients' risk of developing several other health conditions

When a patient is diagnosed with eczema, the diagnosis of another medical condition may not be far behind.

28 Jul 2016

Study finds link between eczema and S. aureus bacteria

A new study published in the British Journal of Dermatology has shown that, on average, 70% of eczema patients are colonised with Staphylococcus aureus bacteria (S. aureus, including MRSA) on their skin lesions.

26 Jul 2016

Laundry pods more likely to cause poisoning injuries in small children than nonpod detergents

Laundry pod detergents are far more likely to cause poisoning injuries in young children than are nonpod laundry detergents, and are four times more likely to lead to hospitalization, according to findings published today from researchers at the University of Alabama at Birmingham.

28 Jun 2016

Early-life peanut consumption feasible and nutritionally safe for children, study finds

Introducing peanut-containing foods during infancy as a peanut allergy prevention strategy does not compromise the duration of breastfeeding or affect children's growth and nutritional intakes, new findings show.

13 Jun 2016

Subcutaneous treatment with cord blood stem cells improves eczema symptoms

A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis.

7 Jun 2016

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.

28 May 2016

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Elimination of the food that triggers atopic dermatitis, or eczema, is associated with increased risk of developing immediate reactions to that food, according to the results of a large-scale study recently published in the Journal of Allergy and Clinical Immunology.

24 May 2016

Domestic water hardness linked to eczema risk in children

High levels of water hardness in the home may be linked to the development of eczema early in life, according to a new study led by King's College London.

18 May 2016

Study shows canine AD shares significant features of human version

Atopic dermatitis (AD), a chronic inflammatory skin condition and the most common form of eczema, is estimated to afflict as much as 10 percent of the U.S. population, and is much more common now than it was 50 years ago. Veterinary clinical estimates also show that approximately 10 percent of dogs have atopic dermatitis.

26 Apr 2016

Researchers observe worrisome increase in anaphylaxis rate

Anaphylaxis, known to be a sudden and potentially life-threatening allergic reaction, seems to be increasing among children, according to a new study led by a team at the Research Institute of the McGill University Health Centre.

22 Apr 2016

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab was superior to adalimumab (marketed by AbbVie as HUMIRA) in improving signs and symptoms in patients with active rheumatoid arthritis (RA) at Week 24.

11 Mar 2016

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME).

22 Feb 2016

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that VIVLODEX (meloxicam) capsules, a nonsteroidal anti-inflammatory drug (NSAID), is now available by prescription at pharmacies across the United States.

16 Feb 2016

Antiscarring paste can halt fibrosis caused by radiation treatment

An antiscarring paste when applied to the skin of mice halts fibrosis caused by the radiation used in cancer therapy. That is according to a study led by researchers at Laura and Isaac Perlmutter Cancer Center to be published tomorrow in the January edition of the Journal of the Federation of American Societies for Experimental Biology, or FASEB.

5 Jan 2016

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune Pharmaceuticals Inc. a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced it has entered into an exclusive license with Atlante Biotech SAS, to the patents and know-how for a new format of bispecific antibodies.

29 Dec 2015

Asthma in childhood may increase risk of shingles

Nearly 1 million incidences of herpes zoster, which is also known as shingles, occur every year in the U.S., with an estimated one-third of all adults affected by age 80. Despite its prevalence, particularly between ages 50 and 59, it is still unclear why some individuals will develop shingles, and others will not.

29 Dec 2015

Lilly, Merck announce another immuno-oncology collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.

10 Dec 2015

New Northwestern Medicine project aims to understand effects of asthma, eczema on children

A new Northwestern Medicine project, "Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments" (AAD-PEPR), will focus on two common childhood diseases that affect almost 25 percent of American children under age 18.

1 Dec 2015

Dermatitis News and Research

Latest Dermatitis News and Research

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Researchers develop new approach to manufacturing mechanical metamaterials

Eczema can increase patients' risk of developing several other health conditions

Study finds link between eczema and S. aureus bacteria

Laundry pods more likely to cause poisoning injuries in small children than nonpod detergents

Early-life peanut consumption feasible and nutritionally safe for children, study finds

Subcutaneous treatment with cord blood stem cells improves eczema symptoms

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Domestic water hardness linked to eczema risk in children

Study shows canine AD shares significant features of human version

Researchers observe worrisome increase in anaphylaxis rate

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Antiscarring paste can halt fibrosis caused by radiation treatment

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Asthma in childhood may increase risk of shingles

Lilly, Merck announce another immuno-oncology collaboration

New Northwestern Medicine project aims to understand effects of asthma, eczema on children

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Dermatitis News and Research

Latest Dermatitis News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in